A pathogenetic role of HCV has been recently postulated in some lympho
proliferative disorders and in particular in essential mixed cryoglobu
linemia. To assess the relevance of HCV infection in multiple myeloma,
Waldenstrom's macroglobulinemia and monoclonal gammopathy of undeterm
ined significance in the absence of cryoglobulinemia (cryo-ve MG), 102
patients were evaluated for antiHCV, HCVRNA and HCV genotypes. A cont
rol group of 466 patients referring for acute trauma to the Orthopedic
Division of our hospital was also studied. The overall prevalence of
HCV was 15.6% in MG patients and 5.4% in the control group (P = <0.001
). Since only patients with MG older than 50 years had HCV infection,
we compared the prevalence rate of infection in patients aged 50 and o
lder: in cryo-ve MG HCV prevalence was 17.9%, while in patients with a
n acute trauma it was 10%; the difference was not statistically signif
icant. In addition, occurrence of cryo-ve MG was investigated in 614 a
ntiHCV+ patients with chronic liver disease and was found in 1.9%. Com
paring all the 28 cryo-ve MG patients HCV+ with an appropriately match
ed control group of HCV+ patients without MG, no difference in severit
y of liver disease and genotype distribution was detected. These findi
ngs show that: (1) among cryo-ve MG, HCV infection is frequent as show
n in the appropriately matched control population; (2) prevalence of c
ryo-ve MG in antiHCV patients with chronic liver disease is similar to
the rate found in the general population; and (3) HCV infection and d
isease do not differ in patients with and without cryo-ve MG.